Login to Your Account



China’s Luye Pharma steps up M&A with $263M buyout of Acino

By Pearl Liu
Staff Writer

Thursday, December 8, 2016

HONG KONG – In yet another of a growing list of acquisitions, Chinese drugmaker Luye Pharma Group Ltd. (2186.HK) has inked an agreement to acquire Swiss-based Acino Holdings’ transdermal drug delivery systems (TDS) business.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription